These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 31567003)

  • 1. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE
    J Am Heart Assoc; 2019 Oct; 8(19):e013543. PubMed ID: 31567003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
    Aung T; Halsey J; Kromhout D; Gerstein HC; Marchioli R; Tavazzi L; Geleijnse JM; Rauch B; Ness A; Galan P; Chew EY; Bosch J; Collins R; Lewington S; Armitage J; Clarke R;
    JAMA Cardiol; 2018 Mar; 3(3):225-234. PubMed ID: 29387889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review.
    Balk EM; Adams GP; Langberg V; Halladay C; Chung M; Lin L; Robertson S; Yip A; Steele D; Smith BT; Lau J; Lichtenstein AH; Trikalinos TA
    Evid Rep Technol Assess (Full Rep); 2016 Aug; (223):1-1252. PubMed ID: 30307737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Yan J; Liu M; Yang D; Zhang Y; An F
    Cardiovasc Drugs Ther; 2024 Aug; 38(4):799-817. PubMed ID: 36103100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials.
    Bernasconi AA; Wiest MM; Lavie CJ; Milani RV; Laukkanen JA
    Mayo Clin Proc; 2021 Feb; 96(2):304-313. PubMed ID: 32951855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
    Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE;
    Circ Res; 2020 Jan; 126(1):112-128. PubMed ID: 31895658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
    Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Multivitamin and Mineral Supplementation and Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis.
    Kim J; Choi J; Kwon SY; McEvoy JW; Blaha MJ; Blumenthal RS; Guallar E; Zhao D; Michos ED
    Circ Cardiovasc Qual Outcomes; 2018 Jul; 11(7):e004224. PubMed ID: 29991644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
    Rizos EC; Ntzani EE; Bika E; Kostapanos MS; Elisaf MS
    JAMA; 2012 Sep; 308(10):1024-33. PubMed ID: 22968891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants.
    Hoang T; Kim J
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Kwak SM; Myung SK; Lee YJ; Seo HG;
    Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Association Between Serum/Dietary Magnesium and Cardiovascular Disease/Coronary Heart Disease Risk: A Dose-Response Meta-analysis of Prospective Cohort Studies.
    Zhao L; Hu M; Yang L; Xu H; Song W; Qian Y; Zhao M
    J Cardiovasc Pharmacol; 2019 Dec; 74(6):516-527. PubMed ID: 31815866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis.
    Rizos EC; Markozannes G; Tsapas A; Mantzoros CS; Ntzani EE
    Heart; 2021 Jan; 107(2):150-158. PubMed ID: 32820013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis.
    Barbarawi M; Kheiri B; Zayed Y; Barbarawi O; Dhillon H; Swaid B; Yelangi A; Sundus S; Bachuwa G; Alkotob ML; Manson JE
    JAMA Cardiol; 2019 Aug; 4(8):765-776. PubMed ID: 31215980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
    ; Bonds DE; Harrington M; Worrall BB; Bertoni AG; Eaton CB; Hsia J; Robinson J; Clemons TE; Fine LJ; Chew EY
    JAMA Intern Med; 2014 May; 174(5):763-71. PubMed ID: 24638908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omega-3 polyunsaturated fatty acid biomarkers and risk of type 2 diabetes, cardiovascular disease, cancer, and mortality.
    Jiang H; Wang L; Wang D; Yan N; Li C; Wu M; Wang F; Mi B; Chen F; Jia W; Liu X; Lv J; Liu Y; Lin J; Ma L
    Clin Nutr; 2022 Aug; 41(8):1798-1807. PubMed ID: 35830775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
    Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
    Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omega-3 Fatty Acid Supplementation and Cardiovascular Disease Risk: Glass Half Full or Time to Nail the Coffin Shut?
    Maki KC; Dicklin MR
    Nutrients; 2018 Jul; 10(7):. PubMed ID: 29973554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.